John Aballi

CEO

Board Member

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

XGN

Current role

CEO, Board Member, CFO

2024-07-31–present

14 calls Latest call 2026-05-11

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Exagen Inc. (XGN)	President, Chief Executive Officer, Director and former Interim Chief Financial Officer	$540,000	—	$402,750	$203,018	$237,600	$17,500	$1,400,868
2024	Exagen Inc. (XGN)	President, Chief Executive Officer, and Director	$525,000	—	$353,500	—	$288,750	$17,250	$1,184,500
2023	Exagen Inc. (XGN)	President, Chief Executive Officer, and Director	$525,000	$76,125	—	—	$317,625	$13,200	$931,950
2022	Exagen Inc. (XGN)	President and Chief Executive Officer	$111,056	$22,330	$850,500	—	—	—	$983,886
2021	Exagen Inc. (XGN)	President and Chief Executive Officer	—	—	—	—	—	—	—

Earnings-call appearances and filed executive appointments or departures, newest first.

Show 2 earlier activities